NCT05948657View on ClinicalTrials.gov

Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Prostate Cancer
Interventions
DIAGNOSTIC_TEST

PSMA-PET CT

Patients will undergo PSMA-PET CT (Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography) at baseline, 12 month and 24 month time point.

Trial Locations (4)

10065

RECRUITING

Weill Cornell Medicine - New York Presbyterian Hospital, New York

44106

NOT_YET_RECRUITING

Case Western University Hospitals, Cleveland

90005

NOT_YET_RECRUITING

UCLA, Los Angeles

94143

NOT_YET_RECRUITING

UCSF, San Francisco

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER